These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2741239

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA, Budzynski AZ.
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Action of proteolytic enzymes on fibrinogen].
    Jamet M, Levy G.
    Ann Anesthesiol Fr; 1978 Mar; 19(8):687-91. PubMed ID: 31111
    [Abstract] [Full Text] [Related]

  • 26. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W, Delvos U, Müller-Berghaus G.
    Thromb Haemost; 1985 Aug 30; 54(2):533-8. PubMed ID: 4082091
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ, Jackson CM.
    J Biol Chem; 1990 Jan 05; 265(1):248-55. PubMed ID: 2294105
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fibrinogen derivatives in plasma.
    Lane DA.
    Br J Haematol; 1981 Mar 05; 47(3):329-35. PubMed ID: 6161635
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The action of a fibrin-promoting enzyme from the venom of Agkistrodon contortrix contortrix on rat fibrinogen and plasma.
    Dyr JE, Suttnar J, Simák J, Fortová H, Kornalík F.
    Toxicon; 1990 Mar 05; 28(11):1364-7. PubMed ID: 2087698
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Fibrin polymerization sites in fibrinogen and fibrin fragments.
    Budzynski AZ, Olexa SA, Pandya BV.
    Ann N Y Acad Sci; 1983 Jun 27; 408():301-14. PubMed ID: 6575691
    [No Abstract] [Full Text] [Related]

  • 39. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
    Galanakis DK, Ghebrehiwet B.
    J Clin Invest; 1994 Jan 27; 93(1):303-10. PubMed ID: 8282801
    [Abstract] [Full Text] [Related]

  • 40. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.
    Dardik BN, Shainoff JR.
    Blood; 1985 Mar 27; 65(3):680-8. PubMed ID: 3971045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.